BIOLASE, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows in 2020. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-05-13: Reporting owner Wagner Elaine C; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-05-13: Reporting owner Sato Garrett; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-05-13: Reporting owner DiTolla Michael; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-05-13: Reporting owner Lanman Richard B.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-05-13 | Wagner Elaine C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +176,045 176,045 owned after | $0.38 exercise price | 2020-05-28 | |
| 2020-05-13 | Sato Garrett Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +176,045 184,880 owned after | $0.38 exercise price | 2020-05-28 | |
| 2020-05-13 | DiTolla Michael Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +176,045 176,045 owned after | $0.38 exercise price | 2020-05-28 | |
| 2020-05-13 | Lanman Richard B. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +176,045 205,084 owned after | $0.38 exercise price | 2020-05-28 | |
| 2020-05-13 | ROPER JESS Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +187,378 187,378 owned after | $0.38 exercise price | 2020-05-28 | |
| 2020-05-13 | LORD JONATHAN T MD Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +330,178 443,659 owned after | $0.38 exercise price | 2020-05-28 |